Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions - Biological and prognostic implications

Gynecologic Oncology

Volumn 83, Issue 2, 2001, Pages 249-256

  Davidson, Ben ^a   Risberg, Bjorn ^a   Berner, Aasmund ^a   Nesland, Jahn M ^a   Tropé, Claes G ^a   Kristensen, Gunnar B ^a   Bryne, Magne ^b   Goscinski, Mariusz ^a   Van de Putte, Gregg ^a   Florenes, Vivi Ann ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cyclin A; Immunoblotting; Immunocytochemistry; Ki 67; p27kip1; Survival

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; KI 67 ANTIGEN; PROTEIN P27;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PERITONEAL CAVITY; PERITONEUM EXUDATE; PLEURA CAVITY; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0034765037     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6388     Document Type: Article

References (35)

1. The hallmarks of cancer
2. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors (CKIs)
3. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia
4. CDK inhibitors: Positive and negative regulators of G1-phase progression
5. Cyclin A: Function and expression during cell proliferation
6. kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
7. Regulation of the Calk inhibitor p27 and its deregulation in cancer
8. kip1 and its alterations in tumor cells: A review
9. Cell adhesion and drug resistance in cancer
10. Global cancer statistics
11. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993
12. Ovarian cancer stages I and II: Predictions and 5-year survival in two decades
13. Detection of cancer cells in effusions from patients diagnosed with gynecological malignancies - Evaluation of five epithelial markers
14. Surface epithelial-stromal tumors
15. WAF1/CIP1 is lost during progression of human malignant melanoma
16. kip1 in malignant melanoma. Inverse correlation with disease-free survival
17. The immunohistochemical expression of proliferating cell nuclear antigen (PCNA/Cyclin) in malignant and benign epithelial ovarian neoplasms and correlation with prognosis
18. Proliferating cell nuclear antigen in epithelial ovarian cancer: Relation to results at second-look laparotomy and survival
19. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas
20. kip1 and cyclin D1 in epithelial ovarian tumors
21. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer
22. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study
23. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma - Evidence of up-regulated Tn and Sialyl Tn antigens expression in effusions
24. E-cadherin and α-,β- and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
25. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
26. kip1 induces N-terminal proteolytic cleavage of cyclin A
27. New functional activities for the p21 family of CDK inhibitors
28. kip1 on resistence of tumor cells to anticancer agents
29. kip1
30. Stage IV ovarian cancer: Impact of surgical debulking
31. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer
32. Expression of membrane-type 1,2 and 3 matrix metalloproteinases (MT1-MMP, MT2-MMP, MT3-MMP) mRNA in ovarian carcinoma cells in serous effusions
33. Up-regulation of CD44s, but not of CD44v3-10, in ovarian carcinoma cells in malignant effusions